THE SHARE: Change: -0.01 SEK (-5.15%) / Price: 0.11 SEK / Jan 2, 2026, 2:42 pm (CET)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

Press Releases

  • 26 Feb, 2019
    Spago Nanomedical to present preclinical data for SpagoPix at ECR
  • 26 Feb, 2019
    Spago Nanomedical presenterar prekliniska data för SpagoPix på ECR
  • 19 Feb, 2019
    Spago Nanomedical receives approval to initiate the clinical trial SPAGOPIX-01
  • 19 Feb, 2019
    Spago Nanomedical får klartecken att starta den kliniska prövningen SPAGOPIX-01
  • 8 Feb, 2019
    Nya data om SpagoPix publicerade i European Journal of Inorganic Chemistry
  • 8 Feb, 2019
    New data on SpagoPix published in European Journal of Inorganic Chemistry
  • 30 Jan, 2019
    Spago Nanomedical bokslutskommuniké januari – december 2018
  • 7 Jan, 2019
    Valberedning utsedd inför årsstämman 2019 i Spago Nanomedical AB
  • 20 Dec, 2018
    Spago Nanomedical submitted application for initiation of the phase I clinical trial SPAGOPIX01
  • 20 Dec, 2018
    Spago Nanomedical har lämnat in ansökan om start av fas I studien SPAGOPIX01
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 21
  • Previous
  • Next
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2026 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications